Log in to save to my catalogue

NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in S...

NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in S...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff1c4ccf767e411f85c1b12a0db8fe55

NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats

Publication information

Publisher

Cambridge: eLife Sciences Publications Ltd

More information

Scope and Contents

Contents

NBI-921352 (formerly XEN901) is a novel sodium channel inhibitor designed to specifically target Na
V
1.6 channels. Such a molecule provides a precision-medicine approach to target
SCN8A
-related epilepsy syndromes (
SCN8A
-RES), where gain-of-function (GoF) mutations lead to excess Na
V
1.6 sodium current, or other indicati...

Alternative Titles

Full title

NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ff1c4ccf767e411f85c1b12a0db8fe55

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff1c4ccf767e411f85c1b12a0db8fe55

Other Identifiers

ISSN

2050-084X

E-ISSN

2050-084X

DOI

10.7554/eLife.72468

How to access this item